Mostrar el registro sencillo del ítem

dc.contributor.authorBryk-Wiązania, Agata Hanna
dc.contributor.authorMinasyan, Mari
dc.contributor.authorŚwiątkowska-Stodulska, Renata
dc.contributor.authorUndas, Anetta
dc.contributor.authorHubalewska-Dydejczyk, Alicja
dc.contributor.authorWebb, Susan M.
dc.contributor.authorValassi, Elena
dc.contributor.authorGilis-Januszewska, Aleksandra
dc.date.accessioned2024-04-05T09:03:03Z
dc.date.available2024-04-05T09:03:03Z
dc.date.issued2024
dc.identifier.citationBryk-Wiązania, Agata Hanna; Minasyan, Mari; Świątkowska-Stodulska, Renata [et al.]. The thrombotic risk in Cushing’s syndrome—questions, answers, and the algorithm to consider in its assessment: part I—thrombotic risk not related to surgery. Frontiers in Endocrinology, 2024, 15, 1350010. Disponible en: <https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1350010/full>. Fecha de acceso: 5 abr. 2024. DOI: 10.3389/fendo.2024.1350010ca
dc.identifier.issn1664-2392ca
dc.identifier.urihttp://hdl.handle.net/20.500.12328/4187
dc.description.abstractIntroduction: Recently, it has been reported that there is a great diversity in strategies used for thromboprophylaxis in patients with Cushing’s syndrome (CS). An aim of this review was to discuss these practices in light of the existing data on the thrombotic risk in patients with CS and guidelines for medically ill patients. Methods: The four relevant topics and questions on thrombotic risk in CS were identified. The current guidelines on prevention and diagnosis of venous thromboembolism (VTE) were reviewed for the answers. An algorithm to consider in the assessment of the thrombotic risk in patients with CS was proposed. Results: To address both generic and CS-specific risk factors for VTE, the algorithm includes the stepwise approach consisting of Padua Score, urine free cortisol, and CS-VTE score, with no indication for routine thrombophilia testing in the prediction of an index VTE episode. Having confirmed VTE, selected patients require thrombophilia testing to aid the duration of anticoagulant treatment. The separate part of the algorithm is devoted to patients with ectopic adrenocorticotropic hormone syndrome in whom exclusion of VTE precedes introducing routine thromboprophylaxis to prevent VTE. The cancer-related VTE also prompts thromboprophylaxis, with the possible vessel invasion. The algorithm presents a unifactorial and multifactorial approach to exclude high-bleeding risks and safely introduce thromboprophylaxis with low-molecular-weight heparin. Summary: Our article is the first to present an algorithm to consider in the thrombotic risk assessment among patients with Cushing’s syndrome as a starting point for a broader discussion in the environment. A plethora of factors affect the VTE risk in patients with CS, but no studies have conclusively evaluated the best thromboprophylaxis strategy so far. Future studies are needed to set standards of care.ca
dc.format.extent15ca
dc.language.isoengca
dc.publisherFrontiers Mediaca
dc.relation.ispartofFrontiers in Endocrinologyca
dc.relation.ispartofseries15
dc.rights© 2024 Bryk-Wiązania, Minasyan, Świątkowska-Stodulska, Undas, Hubalewska-Dydejczyk, Webb, Valassi and Gilis-Januszewska. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.ca
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.otherSíndrome de Cushingca
dc.subject.otherSíndrome de l'hormona adrenocorticotròpica ectòpicaca
dc.subject.otherTromboembolisme venósca
dc.subject.otherRisc trombòticca
dc.subject.otherTromboprofilaxica
dc.subject.otherSíndrome de Cushingca
dc.subject.otherSíndrome de hormona adrenocorticotrópica ectópicaca
dc.subject.otherTromboembolismo venosoca
dc.subject.otherRiesgo trombóticoca
dc.subject.otherTromboprofilaxisca
dc.subject.otherCushing's syndromeca
dc.subject.otherEctopic adrenocorticotropic hormone syndromeca
dc.subject.otherVenous thromboembolismca
dc.subject.otherThrombotic riskca
dc.subject.otherThromboprophylaxisca
dc.titleThe thrombotic risk in Cushing’s syndrome—questions, answers, and the algorithm to consider in its assessment: part I—thrombotic risk not related to surgeryca
dc.typeinfo:eu-repo/semantics/articleca
dc.description.versioninfo:eu-repo/semantics/publishedVersionca
dc.rights.accessLevelinfo:eu-repo/semantics/openAccess
dc.embargo.termscapca
dc.subject.udc61ca
dc.identifier.doihttps://dx.doi.org/10.3389/fendo.2024.1350010ca


Ficheros en el ítem

 

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

© 2024 Bryk-Wiązania, Minasyan, Świątkowska-Stodulska, Undas, Hubalewska-Dydejczyk, Webb, Valassi and Gilis-Januszewska. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Excepto si se señala otra cosa, la licencia del ítem se describe como http://creativecommons.org/licenses/by/4.0/
Compartir en TwitterCompartir en LinkedinCompartir en FacebookCompartir en TelegramCompartir en WhatsappImprimir